Introduction
The human microsomal cytochrome P450, CYP17A1, is a key enzyme in steroid hormone biosynthesis, which is capable of both hydroxylase and carbon-carbon lyase activity in a series of chemical transfomations of pregnenolone that give rise to corticoid precursors and androgens. In human adrenal steroidogenesis, the hydroxylation process predominates in the adrenal zona fasciculata, where D5 (pregnenolone, PREG) and D4 (progesterone, PROG) steroid are converted into the 17a-hydroxy products OH-PREG and OH-PROG, respectively, by insertion of an oxygen into a C-H bond. In the adrenal zona reticularis, each of these hydroxylated products are converted to the estrogen and testosterone precursors dehydroepiandrosterone (DHEA) and androstenedione (AD) via 17,20-carbon-carbon bond scission in which the 21-carbon 17a-hydroxysteroids are cleaved to 19-carbon, 17-ketosteroids, and acetic acid [1] . This compartmentalization of CYP17A1 behavior in the adrenal gland is thought to be controlled by co-localization with its putative allosteric effector cytochrome b 5 (cyt-b 5 ) in the adrenal zona reticularis [2] [3] [4] . Interaction between CYP17A1 and cyt-b 5 is known to substantially stimulate C-C lyase activity of this enzyme such that its presence can be considered essential for lyase chemistry. Furthermore, the absence of CYP17A1 in the adrenal zona glomerulosa helps to direct steroidogenesis in this region toward mineralocorticoid aldosterone production. As a result, varying expression levels of CYP17A1 and cyt-b 5 throughout the adrenal gland controls an important branch point in human steroidogenesis between glucocorticoid and sex hormone biosynthesis. It has been shown that both PREG and PROG are good substrates for human CYP17A1 for the 17a-hydroxylase reaction, however, 17-OH-PREG is preferred over 17-OH-PROG for the 17,20-lyase reaction [5] [6] [7] .
The C-C lyase reaction catalyzed by CYP17A1 is notable not only for the profound rate enhancement exerted by association studied the T306A mutant of CYP17A1, using D5-steroids (PREG and 17-OH-PREG) as substrates [9] . Other reports of CYP17A1 activity used various subsets of D4-and D-5-steroids as substrates and detergent solubilized CYP17A1 reconstituted with CPR and cyt-b 5 at different stoichiometries [8, 9, [28] [29] [30] , which makes a direct comparison of the hydroxylase and lyase activity for specific D4-or D5-steroids difficult. To overcome these shortfalls, we incorporated CYP17A1 and its variant T306A in Nanodiscs and reconstituted it with redox partners in a well controlled stoichiometry [31, 32] . We also employed the consistent substrate sets, the D5 (PREG and 17-OH-PREG) and D4 (PROG and 17-OH-PROG) steroids to study the hydroxylase and lyase activity using the same preparation of cytochrome P450 reductase (CPR) and cyt-b 5 throughout the in vitro reconstitution experiments. Importantly, we also documented the preference of substrate and coupling efficiency during the hydroxylation and lyase reaction by the wild type CYP17A1 and its mutant T306A.
Materials and methods

Construction of T306A
In order to obtain the conserved I-helix variant of human CYP17A1 T306A, the pCWori_CYP17A1 construct [7] was mutated using primers 5 0 -ggt gcc ggt gtg gaa gcc acc acc agc gtc gtc-3 0 (forward) and 5 0 -gac gac gct ggt ggt ggc ttc cac acc ggc acc-3 0 (reverse). The sequence of the mutant was verified by automated DNA sequencing (ACGT, Inc.).
Expression and purification of recombinant proteins
The expression and purification of T306A was performed as described for wild type CYP17A1 [7, 33] . The expression and purification of membrane scaffold protein (MSP), rat P450 reductase (CPR) and cyt-b 5 was performed as described [34] [35] [36] .
Nanodisc assembly of T306A
The detailed protocol for the incorporation of CYP17A1 into Nanodiscs has been previously reported [7, 33] and same procedure was employed for the T306A mutant.
Spectroscopic characterization
UV-visible spectra for CYP17A1 and T306A were recorded at room temperature using a Cary 300 UV-visible spectrophotometer. The P450 concentration was estimated by CO-difference spectra assuming De(450-490) = 91 mM À1 cm À1 as described [37] .
NADPH oxidation
Incorporation of CPR into preformed and purified CYP17A1 (or T306A) Nanodiscs was made by direct addition of oligomeric CPR at 1:4 CYP17A1 (or T306A)/CPR molar ratio, as described [38] . Briefly, 1 ml of CYP17A1 (or T306A) and CPR solution, in presence or absence of cytochrome b 5 (1:4:4 M ratio), in 100 mM potassium phosphate buffer, pH 7.4, containing 50 mM NaCl and 50 lM substrate (PROG, 17-OH-PROG, PREG or 17-OH-PREG) was brought 37°C in a stirred quartz cuvette. The sample was incubated for 5 min and the reaction was initiated by addition of 100 lM of NADPH. The consumption of NADPH was monitored by recording the absorbance at 340 nm for 5 min. The reaction was stopped by adding 50 ll of 9 M sulfuric acid to bring the pH below 4.0. The sample was removed from the cuvette, flash frozen in liquid nitrogen, and stored at À80°C until product analysis. The optical (1), formation of a high spin ferric state (2), transfer of an electron from the redox partner to form the ferrous protein (3), generation of the ferrous oxygenated (oxy-ferrous) state (4), reduction to form the peroxo states after receiving second electron (5a), transfer of proton to the distal oxygen atom and production of the ''hydroperoxo'' state (5b), a second protonation and formation of a higher valent metal-oxo species ''Compound I'' (Cpd I) (6) , and the hydroxylation and release of product (7) measurements were performed on Hitachi U-3300 spectrophotometer supplied with temperature controller and built-in magnetic stirrer. For 17-OH-PROG and 17-OH-PREG assay a threefold higher concentration of NADPH was used with a path length of 0.4 cm rather than 1 cm. The rate of NADPH oxidation was determined from the slope of absorption at 340 nm during the first 2 min using an extinction coefficient of 6.22 cm À1 mM À1 .
Catalytic turnover
Analysis of the hydroxylated and lyase products of D4-and D5-steroids by CYP17A1 and T306A was performed as follows.
The conversion of PREG to 17-OH-PREG was analyzed by TLC (EMD TLC Silica gel 60 F254, 20 Â 20 cm), using radiolabeled H] pregnenolone (8.5 nmol, 0.8 lCi) as described [39] . The conversion of PROG to 17-OH-PROG was analyzed by HPLC (Waters).
Briefly, 1 ll of 27 mM cortexolone solution in methanol were added to 500 ll each of the reaction sample and vortexed for 10 s. 2 ml of chloroform was added to each aliquots and vortexed for 30 s. The organic phage was removed and dried under the stream of nitrogen. The dried sample was dissolved in 100 ll of methanol and 40 ll was injected onto C 18 -HPLC column, using a 150 Â 2.1 mm, 3 lm (ACE-111-1502) with the mobile phase of 45% each of methanol and acetonitrile in water and a flow rate of 0.2 ml/min. The 17-hydroxylated product of PROG was separated in the linear gradient of methanol and acetonitrile from 20% to 80% in 28 min. Peak integration was performed with GRAM/32 software (Thermo Fischer Scientific). The analysis of 17-hydroxylated product of both D4-and D5-steroids was performed on an FID equipped gas chromatograph (Agilent 6890) as described [39] .
Results
3.
1. Expression, purification, spectrophotometric characterization and assembly of T306A Nanodiscs
The mutant protein T306A was successfully overexpressed and purified from the bacterial membrane. The protein was pure by SDS-PAGE with a mass of $58 kDa. The yield of the protein was 4-6 mg/L Escherichia coli cell culture. The oxidized, reduced and CO-complexed spectra of the progesterone bound T306A displayed the Soret band at 391 nm, a diminished absorption maximum at 408 and 447 nm, respectively. The mutant protein was incorporated into Nanodiscs and the purity was confirmed by SDS-PAGE and HPLC size exclusion chromatography. The oxidized substrate free T306A showed the characteristic absorption maxima: Q bands at 568 nm (a band) and 535 nm (b band), and the Soret band at 417 nm. The pronounced Soret peak at 417 nm in the absence of substrate was shifted to 391 nm by the addition of progesterone. The reduced protein displayed a peak maximum at 408 nm and the reduced CO-complex showed a typical ''P450'' peak at 447 nm.
3.2. NADPH oxidation and turnover of D4-and D5-steroids by CYP17WT and T306A
The rates of pyridine nucleotide oxidation and product formation were measured for T306A and compared with that of the wild type enzyme. We evaluated both the hydroxylase and lyase activities in the presence of D4-and D5-steroids. Using PREG and PROG as substrates, the ''normal'' hydroxylation reaction is followed by the production of the 17a-OH product. Using 17-OH-PREG and 17-OH-PROG allowed us to specifically examine the 17,20-carbon-carbon lyase reaction of the corresponding substrates by monitoring the production of dehydroepiandrosterone (DHEA) and androstenedione (AD), respectively. Since Thr306 is a member of the conserved acid/alcohol pair and thought to be essential for the efficient delivery of protons required for hydroperoxoanion heterolysis and formation of Cpd I in P450cam [16, 28, 18] , the change of T306A at the analogous position in CYP17A1 would be expected to disrupt the Cpd I mediated hydroxylation chemistry. We observed that T306A consumed NADPH at about 6.6 and 2.3 times faster than WT during the conversion of PREG and PROG, respectively, to their corresponding 17a-OH product ( Fig. 2A , Table 1 ). However, the product formation rate was dramatically reduced by $94% and 92% (Fig. 2B , Table 1 ). As a result, the coupling efficiency of T306A was less than 1% during the hydroxylation of PREG and PROG as compared to 97% and 22%, for WT (Fig. 2C ). These two reactions were highly uncoupled in T306A mutant where reducing equivalents and protons are funneled into the formation of superoxide and hydrogen peroxide without O-O bond cleavage rather than productive hydroxylation of the substrates. This suggests the disruption on proton delivery to the distal oxygen atom of the peroxoanion which is required to initiate O-O bond scission and formation of the Cpd I reactive intermediate. These results are consistent with previous investigations of P450cam [16, 40] and other systems, in which mutation of this critical residue severely impairs formation of Cpd I with a concomitant decoupling of product formation from NADPH oxidation. On the other hand, catalysis of carbon-carbon bond scission by the T306A mutant was largely unimpeded by disruption of the CYP17A1 acid-alcohol pair (Fig. 3, Table 1 ). During carbon-carbon bond scission reaction monitored by the conversion of 17-OH-PREG to DHEA, the rate of NADPH oxidation was almost similar 21 vs 17 nmol/min/nmolP450 for WT and T306A, respectively, and did not show the dramatic difference in coupling (4% vs 2% for WT and mutant) (Fig. 3 , Table 1 ). Likewise, the lyase reaction of 17a-OH-PROG to AD also showed the similar rates, having moderately increasing rate of NADPH consumption in T306A mutant, of NADPH oxidation of 26 vs 36 nmol/min/nmolP450 with the coupling of 1.3% vs 0.3% for WT and T306A. However, in both the lyase reactions, we did not observe dramatic changes like the one that we have observed during hydroxylase activity. These data suggested that C-C lyase chemistry conducted by CYP17A1 proceeds independently of the proton delivery pathway and O-O bond scission and Cpd I formation and are consistent with a reactive peroxo anion that initiates the 17,20-lyase activity through nucleophilic attack on the 20-keto group of the substrate [39] .
Effect of cytochrome b 5 on the lyase reaction
It is well documented that cyt-b 5 augments the 17,20-carboncarbon bond scission of mammalian CYP17 [2, 3, [41] [42] [43] , although detailed studies as a function of the P450:CPR:cyt-b 5 ratio have not been reported. Therefore, we explored the effect of cyt-b 5 during lyase activity on our well defined assay system consisting of CYP17A1 Nanodiscs and co-incorporated CPR and cyt-b 5 . We unambiguously observed the preference of 17-OH-PREG (>2-fold higher compared to 17-OH-PROG) during 17,20-lyase activity for both the WT and T306A (Fig. 4, Table 1 ) in presence of cyt-b 5 . It Table 1 Comparison of hydroxylation and lyase reactivities of D5-and D4-steroids by human CYP17A1. has also been shown that the human, bovine, ovine and caprine CYP17 enzymes use 17OH-PREG as a preferred substrate for the 17,20-lyase reaction [3, 41, 42, [44] [45] [46] . In this study, we also observed that the presence of cyt-b 5 enhanced the lyase activity by $5-and 7-fold in the WT and $5-and 4-fold in T306A for 17-OH-PREG and 17-OH-PROG, respectively. Though a detailed mechanism for cyt-b 5 participation in catalysis is not clear, the most recent study on NMR chemical shift mapping of cyt-b 5 titrations with CYP17A1 by Scott's group [47] showed evidence that cyt-b 5 and CPR compete for a binding surface on CYP17A1, and the CYP17A1/cyt-b 5 interaction is stronger in the presence of hydroxylase substrate pregnenolone in the CYP17A1 active site than when the presence of lyase substrate 17a-OH-progesterone.
D5-
In conclusion, we have shown that the highly conserved acidalcohol pair in human CYP17A1 supports a proton delivery pathway necessary only for oxygen-oxygen bond scission to form Cpd I which initiates normal hydroxylation process. This residue, and the associated proton delivery, is not operating the lyase reaction. The unique response of CYP17A1 lyase activity to mutation of Thr306 is consistent with a reactive intermediate formed independently of proton delivery in the active site and suggests the involvement of a nucelophilic peroxo-anion rather than the traditional Cpd I.
Mechanism of the Third Oxidative
Step in the Conversion of Androgens to Estrogens by Cytochrome P450 19A1 Steroid Aromatase ) have both been proposed in the literature as the active iron species in the third step, yielding an estrogen and formic acid. Incubation of purified aromatase with its 19-deutero-19-oxo androgen substrate was performed in the presence of 18 O 2 , and the products were derivatized using a novel diazo reagent. Analysis of the products by high-resolution mass spectrometry showed a lack of 18 O incorporation in the product formic acid, supporting only the Compound I pathway. Furthermore, a new androgen 19-carboxylic acid product was identified. The rates of nonenzymatic hydration of the 19-oxo androgen and dehydration of the 19,19-gem-diol were shown to be catalytically competent. Thus, the evidence supports Compound I and not ferric peroxide as the active iron species in the third step of the steroid aromatase reaction.
■ INTRODUCTION
Androgens are converted to estrogens by the steroid aromatase, cytochrome P450 (P450 or CYP) 19A1. This reaction is essential in maintenance of hormone balance.
1,2 P450 19A1 is also an important target for drugs used in treating estrogendependent cancers. 3 The conversion of an androgen (androstenedione or testosterone) to an estrogen is a threestep process (Scheme 1, I to IV). The first two steps are relatively straightforward and can both be rationalized in the context of a perferryl "Compound I" (FeO 3+ ) P450 intermediate (M7, Scheme 2).
There has been considerable controversy regarding the mechanism of the third step, however, and at least five proposals have been made, including 1β-and 2β-hydroxylation, 4,5-epoxidation, a concerted Compound I mechanism not involving a stable hydroxyl product, and the use of a preceding ferric peroxide form of the enzyme in the catalytic cycle (M5, Scheme 2). 4 (M7, Compound I) mechanism (Scheme 3, step 3b) should not lead to the recovery of an 18 O atom in the product formic acid (Vb), but an FeO 2 − (M5) mechanism (Scheme 3, step 3a) will (Va). Akhtar et al. 12, 15 reported 60% and 90% incorporation of one 18 O atom into formic acid, and Caspi et al. 9 reported 70% incorporation, all in studies with human placental microsomes. These results have provided the major evidence for a FeO 2 − mechanism or possibly a mixed mechanism with the FeO 2 − pathway being dominant (Scheme 3, step 3a).
■ EXPERIMENTAL SECTION
The experimental procedures are provided in detail in the Supporting Information.
■ RESULTS Overall Strategy. Several experimental results would clarify the mechanism of the final aromatization step of P450 19A1 (Scheme 3, steps 3a and 3b). The ferric peroxide (Scheme 3, step 3a) mechanism is supported if: (i) one 18 O atom is incorporated into the formic acid product (Scheme 3, Va) in the incubation of 19-oxo androgen in atmospheric 18 O 2 with P450 19A1 and (ii) the aldehyde (Scheme 3, III-o) is required as the substrate for the carbon−carbon bond cleavage step.
In light of the critical nature of the previously reported 18 O 2 incorporation experiments, we re-examined the findings with purified recombinant human P450 19A1 and newer analytical methods. The analysis of trace formic acid is difficult due to the presence of endogenous levels of the compound in laboratory reagents, and (as did Akhtar et al.) 12 we prepared [19- 2 H]-labeled 19-oxo androstenedione (Figure 2, 4-o) and testosterone substrates (i.e., 19-CDO androgens) to improve the MS analysis, with a shift of +1 amu ( Figure S1 , Supporting Information). In addition, a new diazo reagent bearing a pyridine moiety was designed for the mass spectrometric detection of the formic acid enzymatic product using electrospray ionization in the positive mode. However, the analysis is still complicated by the 13 C natural abundance contribution (1.109% of 12 C) from endogenous formic acid. Accordingly, high-resolution mass spectrometry (HRMS) was used (at a resolution of 100 000) to distinguish 2 HCO 2 H from the H 13 CO 2 H natural abundance peak present in endogenous formic acid.
Second, the enzymatic and nonenzymatic rates of oxygen exchange between the 19-aldehyde (Scheme 3, III-o) and water would indicate whether or not the aldehyde is required as the substrate for the third step. Several case scenarios can arise from the oxygen exchange rate measurements. One is if the nonenzymatic gem-diol dehydration rate to the aldehyde (Scheme 3, nonenzymatic k dehydration , III-g to III-o) is faster than the enzymatic rate of 19-hydroxy androgen to estrogen (Scheme 3, II to IV), then either the aldehyde or the gem-diol is a possible substrate for the final step. The method to determine the gem-diol dehydration rate (k dehydration ) requires two experimental measurements: the distribution of the gem-diol Step 3b, the FeO 3+ form of the P450 19A1 abstracts the 1β-hydrogen atom of gem-diol III-g (III-g: III-gem-diol). Electron transfer yields the carbocation IIIb″-g, which collapses to yield the estrogen product IV. In Step 3a, the formic acid must contain label ( 18 O) but not in Step 3b. "*O" = " 18 O". The step 3(b) pathway is supported by the current study. and aldehyde in water through proton NMR (K eq ) and the exchange rate of the aldehyde oxygen in water over time (k obs 18 O atoms into the 3-and 17-ketone groups, which complicated the measurements for detecting the aldehyde oxygen exchange.)
If the nonenzymatic gem-diol to aldehyde dehydration rate is slower than the enzymatic estrogen formation rate from 19-hydroxy androgen (II to IV), then the comparison to the enzymatic dehydration rate is necessary to show whether or not the enzyme catalyzes the dehydration of the gem-diol to the aldehyde. The ferric peroxide mechanism would be supported in the case where the enzyme catalyzes the dehydration of the gem-diol (Scheme 3, enzymatic k dehydration : III-g to III-o), while the Compound I mechanism could potentially use either the aldehyde (III-o) or the gem-diol (III-g) as the substrate (water may hydrate the aldehyde to the gem-diol at the radical intermediate stage if Compound I initially abstracts the 1β-hydrogen atom of aldehyde III-o, Scheme 4: IIIb′-o to IIIb′-g). In order to simplify our results, we present the data obtained with the androstenedione series in this report; however, the results from the testosterone series are consistent with the androstendione work and are included in the Supporting Information.
New Diazo Reagent for Formic Acid Detection by MS (ESI-Positive Mode). We designed and synthesized a new diazoalkane reagent (1-diazo-3-(3-pyridinyl)propane, 2) for formic acid derivatization and analysis, in order to utilize liquid chromatography (LC)−mass spectrometry (MS) for increased sensitivity. The diazo reagent (2) was accessed by treating a nitrosourea precursor with base. Freshly prepared diazo reagent (2) was added directly to an extract of the incubation that was treated with HCl at 0°C. Control experiments established that significant oxygen exchange of the formic acid (<6%) did not occur with the medium (H 2 18 O) under these conditions (Figure 1 Caspi et al. 9 The isotopic labeling patterns can clearly be seen in the LC−MS traces (3b vs 3c) and in the full spectra generated in the analyses (Figure 2 and Figures S4 and S5 , Supporting Information). In control experiments, P450 3A4 routinely incorporated >98% of the label (one atom) from 18 O 2 in the oxidation of testosterone to 6β-hydroxytestosterone, as expected 24 (this control experiment was done along with each set of incubations with P450 19A1) ( Figure S3 , Supporting Information).
19-Carboxylic Acid Product Supports Compound I Formation. Our previous work on the kinetics and processivity of androstenedione oxidation by purified P450 19A1 had shown slightly less estrone produced than androstenedione oxidized in single turnover assays, 25 suggestive of additional products. Careful analysis of the oxidation of 19-oxo-androstenedione and -testosterone revealed the presence of two new peaks in each case, either using LC−MS ( Figure S6 , Supporting Information) or 14 C-HPLC ( Figure S7 , Supporting Information). One product is the 19-CO 2 H (19-oic acid) derivative, and this assignment was confirmed by coincident chromatography with an authentic sample in the case of androstenedione 19-oic acid, as well as by MS analysis of the propylpyridine ester derivatives (6a and 6b, Figure 3 and Figure  S6 of Supporting Information).
From the knowledge of this novel 19-oic acid aromatase product, a Compound I mechanism suggests a distribution of products arising from a 1β-hydrogen atom abstraction or a 19-hydrogen atom abstraction of the 19-oxo androgen substrate to yield either the estrogen or carboxylic acid, respectively, in the incubation with P450 19A1. Although the 19-oic acid product is minor based on the [4- 14 C]-androstenedione substrate incubation with P450 19A1 (∼95:5, estrogen:carboxylic acid, Figure S8 of Supporting Information), the derivatization of products with the diazo reagent (2) allowed for simultaneous detection of the derivatized carboxylic acid and estrogen products in one LC−MS run in the ESI-positive mode. The diazo reagent (2) had reacted with the carboxylic acid group of 19-oic androstenedione (5b) to afford the ester (6b) and also reacted with the phenol moiety of estrone (4A) to furnish a phenolic ether ( Figure S11, Supporting Information) . The use of a deuterium-labeled substrate such as [19- In addition, another product (M + 18) was formed from both 19-oxo androgen substrates (from 18 O 2 ) (Figures S6, Supporting Information), corresponding to the addition of a single oxygen atom, but the site of oxidation has not been established. The 19-oic acid had been reported to be present in hog follicles 27 but had not actually been demonstrated to be an aromatase product. This product (the 19-oic acid of either androstenedione or testosterone) appears to be stable and was not converted to an estrogen (or 19-norandrogen) in P450 19A1 incubations. The identity of the mono-oxygenated aldehyde product is unknown; like the 19-oic acid, it appears to be an end product ( Figure S8 , Supporting Information). Moreover, the 19-oic androstenedione derivative contained an 18 O atom, which confirms the retention of the oxygen atoms in As we have noted previously in this laboratory 32 and known since the earlier aromatase studies, 12 MS analysis of formic acid is not trivial due to the background contamination problem; HRMS clearly reveals the presence of interfering materials ( Figure 1 and Figures 2C, S4 , and S5, Supporting Information), even with high-resolution LC separation. Prior to use, the laboratory reagents were filtered with basic alumina in order to remove endogenous formic acid; however, the contaminant (3c) was still present in the analyses of the incubation products ( Figure 2C ). In order to completely resolve the [ 2 H]-formate (3b, m/z 167.0925) from [
13 C]-formate (3c, m/z 167.0896), a minimum resolution setting of 60 000 on the LTQ Orbitrap mass spectrometer was required (17.4 ppm mass difference between 3b and 3c, Supporting Information). The use of lowresolution mass spectrometers such as the one used in the Akhtar report (i.e., AEI MS 30 mass spectrometer with 1000 resolution setting) 31 would definitely not be able to distinguish between the two benzyl formate isotopomers with a 21.9 ppm mass difference (i.e., [ 2 H]-benzyl formate with m/z 137.0582 vs [
13 C]-benzyl formate with m/z 137.0552). This observation is based solely on our data because there are no mass spectra for the benzyl formates previously published for comparison. 9, 12, 15 Altogether, our work differs from previous studies in that we used a purified P450 19A1 enzyme, a sensitive new reagent to derivatize formic acid for LC−MS (1-diazo-3-(3-pyridinyl)-propane 2), and, in particular, HRMS analysis to resolve the formic acid derived from the enzyme incubation (3b) and from background contamination (3c). Additionally, the use of the new diazo reagent made it possible to detect the novel 19-oic androgen product as the derivatized ester containing an 18 O atom (Figure 3, 6a) .
against a role for a 2β-hydroxy intermediate may be suspect in light of the issues with the 18 O formic acid analysis. However, the rate of nonenzymatic decomposition of 2β-hydroxy 19-oxoandrostenedione (0.0013 s −1 at pH 7.4) 34 is too slow to be catalytically competent (cf. k cat 0.42 s −1 for the conversion of the 19-oxoandrostenoedione to estrone) 25 (the rate has not been measured in the presence of enzyme).
Some other P450 enzymes have also been proposed to utilize FeO 2 − chemistry. 20 We do not know if our conclusions with P450 19A1 apply to these, although our approach may be employed. However, the steroid aromatase reaction is best explained by classic FeO 3+ chemistry (Scheme 5).
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